RA Capital Management - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 117 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$22,876,000
+0.5%
1,023,0670.0%0.34%
+8.5%
Q4 2020$22,753,000
+50.7%
1,023,0670.0%0.32%
+15.2%
Q3 2020$15,100,000
-0.4%
1,023,0670.0%0.28%
-6.4%
Q2 2020$15,162,0001,023,0670.30%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,843,388$27,208,0005.07%
Aisling Capital Management LP 1,025,000$15,129,0004.83%
BVF INC/IL 2,470,678$36,467,0001.99%
Ghost Tree Capital, LLC 425,000$6,273,0001.81%
VR Adviser, LLC 625,710$9,235,0001.81%
FRAZIER MANAGEMENT LLC 1,320,045$19,484,0001.75%
Avidity Partners Management LP 1,854,100$27,367,0001.27%
Boxer Capital, LLC 2,287,782$33,768,0001.17%
ACUTA CAPITAL PARTNERS, LLC 240,744$3,553,0000.96%
683 Capital Management, LLC 828,371$12,227,0000.90%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders